POUCHITIS
Clinical trials for POUCHITIS explained in plain language.
Never miss a new study
Get alerted when new POUCHITIS trials appear
Sign up with your email to follow new studies for POUCHITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to ease pouch disorder symptoms
Disease control Recruiting nowThis study tests if mirikizumab can reduce symptoms like frequent bowel movements and urgency in adults with chronic pouch inflammation. About 25 participants will receive the drug every 4 weeks for a year and track their symptoms. The goal is to see if the treatment helps contro…
Matched conditions: POUCHITIS
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for pouchitis sufferers: drug and diet combo under study
Disease control Recruiting nowThis study tests whether the drug guselkumab, alone or with a special diet, can help people with chronic pouchitis—a painful inflammation of the internal pouch after ulcerative colitis surgery. Twenty adults who have not responded to antibiotics will receive the drug for 48 weeks…
Matched conditions: POUCHITIS
Phase: PHASE4 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New hope for pouchitis sufferers: experimental drug CLF065 enters phase 2 trial
Disease control Recruiting nowThis study tests an experimental drug called CLF065 for adults with chronic pouchitis, a condition causing inflammation in a surgically created internal pouch. The goal is to see if weekly doses of CLF065 are safe and more effective than a placebo at reducing symptoms and inflamm…
Matched conditions: POUCHITIS
Phase: PHASE2 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New hope for kids with pouchitis: drug trial launches
Disease control Recruiting nowThis study tests a drug called vedolizumab in children with chronic pouchitis, an inflammation of an internal pouch created after bowel surgery. About 30 children will receive up to 12 infusions over about 18 months. The goal is to see if the drug can reduce symptoms and pouch in…
Matched conditions: POUCHITIS
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 11, 2026 20:46 UTC